Science Explorer Back to mapMap
Discussion
Company · Reinach · Switzerland

Evolva (Switzerland)

evolva.comROR OpenAlex
Research works
14
▼ 91% vs 2018-21
Citations
471
32.6 per fractional work
Top-10% rate
25.0%
all institutions 10.0%
Open access
83%
world 40%
International
63%
world 18%
Evolva (Switzerland)

Not ranked overall: Evolva (Switzerland) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Evolva (Switzerland) work in?

In all years, 50% of research at Evolva (Switzerland) is in Life Sciences, 42% in Health Sciences. Its largest fields are Medicine (40%), Biochemistry, Genetics and Molecular Biology (36%), Agricultural and Biological Sciences (10%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 7 fractional works · 50.4% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 36.2% of its workMolecular Biology: 4 fractional works · 29.1% of its workBiotechnology: 1 fractional works · 4.7% of its workBiochemistry: 0 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.3% of its workMolecular Medicine: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 2 fractional works · 10.4% of its workPlant Science: 1 fractional works · 4.0% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 2.5% of its workFood Science: 0 fractional works · 1.6% of its workAgronomy and Crop Science: 0 fractional works · 1.2% of its workAnimal Science and Zoology: 0 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 3.5% of its workPharmaceutical Science: 0 fractional works · 2.3% of its workPharmacology: 0 fractional works · 1.2% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workHealth Sciences: 6 fractional works · 41.7% of its workMedicine: 6 fractional works · 40.1% of its workPharmacology: 2 fractional works · 13.3% of its workEpidemiology: 1 fractional works · 5.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 4.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.9% of its workInfectious Diseases: 0 fractional works · 2.6% of its workDermatology: 0 fractional works · 2.3% of its workHepatology: 0 fractional works · 2.3% of its workBiochemistry: 0 fractional works · 1.8% of its workPsychiatry and Mental health: 0 fractional works · 1.6% of its workGeriatrics and Gerontology: 0 fractional works · 0.9% of its workComplementary and alternative medicine: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 1.2% of its workNutrition and Dietetics: 0 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.5% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 7.9% of its workMaterials Science: 1 fractional works · 5.7% of its workMaterials Chemistry: 0 fractional works · 3.5% of its workBiomaterials: 0 fractional works · 2.3% of its workEngineering: 0 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workALL ITS WORKEvolva(Switzerland)14fractional works, all years
Life Sciences50%Physical Sciences8%Health Sciences42%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology536.2%
    2. Agricultural and Biological Sciences210.4%
    3. Pharmacology, Toxicology and Pharmaceutics03.5%
    4. Neuroscience00.3%
    1. Medicine640.1%
    2. Nursing01.2%
    3. Health Professions00.5%
    1. Materials Science15.7%
    2. Engineering01.4%
    3. Computer Science00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Evolva (Switzerland)?

Ranked on the quality score, Michael Næsby and Harald Heider lead among researchers whose main affiliation is Evolva (Switzerland).

  1. 1 Michael Næsby Switzerland · #1,211,203 worldwide 1.1k citations · 32 works
  2. 2 Harald Heider Switzerland · #3,323,703 worldwide 385 citations · 16 works
All ranked researchers at Evolva (Switzerland)

What are the most cited papers from Evolva (Switzerland)?

The most cited paper from Evolva (Switzerland) is "Engineering prokaryotic transcriptional activators as metabolite biosensors in yeast" (Mette L. Skjoedt, Tim Snoek, Kanchana Rueksomtawin Kildegaard et al., 2016), with 253 citations. Next come "Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties" (123) and "Oxidation and cyclization of casbene in the biosynthesis of Euphorbia factors from mature seeds of Euphorbia lathyris L." (99).

Most cited papers
#PaperReleasedCitations
1 Engineering prokaryotic transcriptional activators as metabolite biosensors in yeast Mette L. Skjoedt, Tim Snoek, Kanchana Rueksomtawin Kildegaard et al. · Nature Chemical Biology 19 Sep 2016 253
2 Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties Michael Eichenberger, Beata Joanna Lehka, Christophe Folly et al. · Metabolic Engineering Open access 31 Oct 2016 123
3 Oxidation and cyclization of casbene in the biosynthesis of Euphorbia factors from mature seeds of Euphorbia lathyris L. Dan Luo, Roberta Callari, Britta Hamberger et al. · Proceedings of the National Academy of Sciences Open access 9 Aug 2016 99
4 Yeast artificial chromosomes employed for random assembly of biosynthetic pathways and production of diverse compounds in Saccharomyces cerevisiae Michael Næsby et al. · Microbial Cell Factories Open access 13 Aug 2009 78
5 Discovery and Reconstitution of the Cycloclavine Biosynthetic Pathway—Enzymatic Formation of a Cyclopropyl Group Dorota Jakubczyk, Lorenzo Caputi, Anaëlle Hatsch et al. · Angewandte Chemie International Edition Open access 25 Feb 2015 75
All 37 most cited papers, with filters and sorting

Which research topics does Evolva (Switzerland) publish most on?

By volume in 2022-now: Telomeres, Telomerase, and Senescence, Skin Protection and Aging, Sirtuins and Resveratrol in Medicine and Antibiotic Resistance in Bacteria.

Telomeres, Telomerase, a…0Telomeres, Telomerase, and Senescence: 0 fractional worksSkin Protection and Aging0Skin Protection and Aging: 0 fractional worksSirtuins and Resveratrol…0Sirtuins and Resveratrol in Medicine: 0 fractional works
PhysiologyDermatologyGeriatrics and Gerontology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Telomeres, Telomerase, and Senescence Physiology 0 works
  2. 2 Skin Protection and Aging Dermatology 0 works
  3. 3 Sirtuins and Resveratrol in Medicine Geriatrics and Gerontology 0 works
  4. 4 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  5. 5 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
  6. 6 Bacterial Genetics and Biotechnology Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available82.6%not open17.4%

World: 40% of research is openly available.

with international co-authors62.6%domestic only37.4%

World: 18% is written across borders.

How has Evolva (Switzerland)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Evolva (Switzerland) as a percentage of every work published that year, 0.0000021% in 2022.

still counting0.000050%0.00010%Evolva (Switzerland)0.0000056% in 202520102020

Fractional works of Evolva (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Reinach

All research institutions in Reinach

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Evolva (Switzerland). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.